Skip to content
Study details
Enrolling now

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Case Comprehensive Cancer Center
NCT IDNCT06101069ClinicalTrials.gov data as of Apr 2026
Target enrollment

60

Study length

about 1.7 years

Ages

21–60

Locations

2 sites in OH

What this study is about

Researchers are testing a new MRI technique called Magnetic Resonance Fingerprinting (MRF) to help doctors see and understand brain tumors better. The trial will use MRF with IVIM MRI, which helps distinguish between tumor recurrence and radiation necrosis after radiotherapy. It involves adults who have received radiation therapy for brain tumors or have had radiation treatment to the brain.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Undergo MRF in conjunction with IVIM MRI without contrast

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Comparison of MRF imaging tool in different participant populations

Procedures

imaging

Body systems

Neurology, Oncology